Order Article Reprints

Langley J, Pastural E, Halperin S, McNeil S, ElSherif M, MacKinnon-Cameron D, Ye L, Grange C, Thibodeau V, Cailhier J-F, et al. A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age. Vaccines. 2020; 8(3):393. https://doi.org/10.3390/vaccines8030393

Langley, Joanne, Elodie Pastural, Scott Halperin, Shelly McNeil, May ElSherif, Donna MacKinnon-Cameron, Lingyun Ye, Cécile Grange, Valérie Thibodeau, Jean-François Cailhier, and et al. 2020. "A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age" Vaccines 8, no. 3: 393. https://doi.org/10.3390/vaccines8030393

Langley, J., Pastural, E., Halperin, S., McNeil, S., ElSherif, M., MacKinnon-Cameron, D., Ye, L., Grange, C., Thibodeau, V., Cailhier, J.-F., Lapointe, R., McElhaney, J., Martin, L., Bolduc, M., Laliberté-Gagné, M.-E., Leclerc, D., & Savard, P. (2020). A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age. Vaccines, 8(3), 393. https://doi.org/10.3390/vaccines8030393